课题基金 / 基金详情

SNX-III ADMINISTERED TO PATIENTS WITH CHRONIC NON-MALIGNANT PAIN

SNX-III ADMINISTERED TO PATIENTS WITH CHRONIC NON-MALIGNANT PAIN
SNX-III 用于慢性非恶性疼痛患者
批准号：
6279163
负责人：
MARK S WALLACE
金额：
$1.43万
依托单位：
UNIVERSITY OF CALIFORNIA, SAN DIEGO
依托单位国家：
美国
项目类别：
财政年份：
1997
资助国家：
美国
项目状态：
已结题
起止时间：
1997-12-01 至 1998-11-30
来源：
https://reporter.nih.gov/project-details/6279163
关键词：
analgesics chronic disease /disorder clinical research dosage drug administration routes drug adverse effect endogenous opioid human subject human therapy evaluation pain

项目摘要

项目成果

MARK S WALLACE的其他基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Assess the safety and efficacy of increasing doses of SNX-111 administered intrathecally to patients with chronic, nonmalignant pain.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
California Clinical and Translational Pain Research Consortium
EFFICACY OF INHALED CANNABIS FOR THE TREATMENT OF PAINFUL DIABETIC NEUROPATHY
EFFICACY OF INHALED CANNABIS FOR THE TREATMENT OF PAINFUL DIABETIC NEUROPATHY
EFFECTS OF SPINAL CORD STIMULATION ON EXPERIMENTALLY INDUCED WIND-UP